Hypertrophic Cardiomyopathy in South Western Nigeria

Código QR

Hypertrophic Cardiomyopathy in South Western Nigeria

AIMS: To evaluate the prevalence of hypertrophic cardiomyopathy (HCM) and its characteristics (clinical, electrocardiographic and echocardiographic) in a hospital population presenting for echocardiography at the Lagos University Teaching Hospital (LUTH). MATERIALS AND METHOD: The echocardiographic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amam Mbakwem, David Oke, Jayne Ajuluchukwu
Formato:	article
Lenguaje:	EN
Publicado:	South African Heart Association 2017
Materias:	hypertrophic cardiomyopathy heart muscle disease nigeria Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/0509a5e79f924696b740bfd8ae968a4b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021)

Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
por: Milind Y. Desai, et al.
Publicado: (2021)

Conduction abnormalities post alcohol septal ablation for hypertrophic cardiomyopathy – A single center experience
por: Avinash Mani, et al.
Publicado: (2021)

Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
por: Hong-Da Zhang, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Qiang Liu, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: a modern view of the problem
por: Amina M. Alieva, et al.
Publicado: (2020)

Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy
por: Dimitrios Ntelios, et al.
Publicado: (2021)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Yang Ye, et al.
Publicado: (2021)

Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Rory Gallen, MB, BcH, BAO, et al.
Publicado: (2021)

Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation
por: Yubi Lin, et al.
Publicado: (2021)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Maike Schuldt, et al.
Publicado: (2021)

Aneurisma apical en paciente con miocardiopatía hipertrófica
por: Alcaino I.,Milton, et al.
Publicado: (2021)

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
por: Sarinya Puwanant, et al.
Publicado: (2021)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Martino Deidda, et al.
Publicado: (2021)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Pratch Sukumolanan, et al.
Publicado: (2021)

Severe peripartum cardiomyopathy: A case report of successful recovery with personalized treatment approach
por: Hamayak S. Sisakian, et al.
Publicado: (2021)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021)

Severe right ventricular hypertrophy in hypertrophic cardiomyopathy: Serious symptoms, complex surgical procedures, and poor prognosis in Fuwai Hospital
por: Xueqi Dong, et al.
Publicado: (2021)

Right ventricular pacing-induced cardiomyopathy: Is there a role for blood biomarkers?
por: Dimitris Tousoulis, et al.
Publicado: (2021)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Elena V. Filatova, et al.
Publicado: (2021)

Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively
por: Jun Gao, et al.
Publicado: (2021)

Left ventricular non-compaction with hypertrophic cardiomyopathy, a mutually beneficial combination?
por: Vijayaraghavan Govindan, et al.
Publicado: (2021)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Luis E. Echeverría, et al.
Publicado: (2021)

Short QT interval as a harbinger of an arrhythmogenic cardiomyopathy
por: Philippe Chevalier, MD, PhD, et al.
Publicado: (2021)

Detection of Congestive Heart Failure and Myocardial Dysfunction in Cats With Cardiomyopathy by Using Two-Dimensional Speckle-Tracking Echocardiography
por: Ryohei Suzuki, et al.
Publicado: (2021)

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
por: Domenico Corrado, et al.
Publicado: (2021)

Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy
por: Cheddadi L, et al.
Publicado: (2017)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

Identification of CALU and PALLD as Potential Biomarkers Associated With Immune Infiltration in Heart Failure
por: Xing Liu, et al.
Publicado: (2021)

Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review
por: Sisi Miao, et al.
Publicado: (2021)

Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain
por: Andreas Ochs, et al.
Publicado: (2021)

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy
por: Adam Gębka, et al.
Publicado: (2020)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Ryan Wallace, et al.
Publicado: (2021)

Time to reconsider risk stratification in dilated cardiomyopathy
por: A. Laina, et al.
Publicado: (2021)

Diabetic Cardiomyopathy: Five Major Questions with Simple Answers
por: Miguel Alejandro Rodriguez-Ramos
Publicado: (2019)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Alexandros Protonotarios, et al.
Publicado: (2020)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: J Gustav Smith, et al.
Publicado: (2021)

Cardiovascular complications of chemotherapy: A synopsis
por: Len Steingo
Publicado: (2017)

Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
por: Jiao Ai, et al.
Publicado: (2021)